2 months ago
NBIX
AnalystsBrian AbrahamsBrian Abrahams's Stock Forecasts
AnalystsBrian Abrahams
Analyst Ranking
Top 9%
#454 out of 5493 analysts
Average Return
+7.16%
Win Rate
50%162 out of 327
Risk vs Reward
Poor
Good
Brian Abrahams's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
89bio IncETNB | +558.80% | $2.67 | $17.59 | 2022-05-12 - 2023-05-11 | Buy |
Pliant Therapeutics IncPLRX | +382.01% | $4.67 | $22.51 | 2022-05-10 - 2023-05-09 | Buy |
Cidara Therapeutics IncCDTX | +372.63% | $46.84 | $221.38 | 2025-06-24 - 2026-01-06 | Buy |
Definium Therapeutics IncDFTX | +265.73% | $11.70 | $42.79 | 2025-11-07 - 2026-08-12 | Buy |
Contineum Therapeutics IncCTNM | +260.66% | $3.94 | $14.21 | 2025-05-15 - 2026-05-14 | Buy |
Brian Abrahams Analyst Color
Get additional color on Brian Abrahams's coverage of popular stocks
6 months ago
NBIX
a year ago
GILD
2 years ago
APLT
2 years ago
DFTX
Brian Abrahams's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Lakefront Biotherapeutics NvLKFT | 14 | Hold | $26.00 | -6.91% | Maintains | 2 days ago |
Nurix Therapeutics IncNRIX | 3 | Buy | $36.00 | +35.19% | Maintains | 3 days ago |
Xenon Pharmaceuticals IncXENE | 22 | Buy | $81.00 | +24.12% | Maintains | 6 days ago |
Evommune IncEVMN | 2 | Buy | $29.00 | +105.38% | Maintains | 6 days ago |
Biocryst Pharmaceuticals IncBCRX | 18 | Buy | $13.00 | +22.76% | Maintains | 7 days ago |
Gilead Sciences IncGILD | 36 | Hold | $123.00 | -9.47% | Maintains | 8 days ago |
Acadia Pharmaceuticals IncACAD | 7 | Buy | $37.00 | +25.64% | Maintains | 8 days ago |
Regeneron Pharmaceuticals IncREGN | 40 | Hold | $737.00 | -7.64% | Maintains | 13 days ago |
Neurocrine Biosciences IncNBIX | 28 | Buy | $198.00 | +26.53% | Maintains | 13 days ago |
Contineum Therapeutics IncCTNM | 7 | Buy | $23.00 | +53.54% | Maintains | 13 days ago |
Biogen IncBIIB | 44 | Buy | $240.00 | +14.90% | Maintains | 14 days ago |
Incyte CorpINCY | 26 | Hold | $109.00 | -9.75% | Maintains | 15 days ago |
Neumora Therapeutics IncNMRA | 8 | Buy | $5.00 | +192.40% | Maintains | a month ago |
Kymera Therapeutics IncKYMR | 3 | Hold | $115.00 | +0.85% | Downgrades | a month ago |
Vertex Pharmaceuticals IncVRTX | 59 | Buy | $570.00 | +8.42% | Maintains | a month ago |
Ptc Therapeutics IncPTCT | 23 | Hold | $85.00 | +17.02% | Maintains | a month ago |
Apogee Therapeutics IncAPGE | 6 | Hold | $135.00 | +0.33% | Maintains | 2 months ago |
Damora Therapeutics IncDMRA | 1 | Buy | $40.00 | +29.03% | Initiates Coverage On | 4 months ago |
Pharvaris NvPHVS | 2 | Buy | $51.00 | +39.88% | Maintains | 4 months ago |
Moonlake ImmunotherapeuticsMLTX | 5 | Hold | $13.00 | -24.55% | Maintains | 5 months ago |
Aardvark Therapeutics IncAARD | 6 | Hold | $6.00 | -8.68% | Downgrades | 5 months ago |
Prothena Corp Public Ltd CoPRTA | 13 | Hold | $12.00 | +29.59% | Maintains | 6 months ago |
Gh Research PLCGHRS | 2 | Buy | $40.00 | +32.28% | Maintains | 7 months ago |
Definium Therapeutics IncDFTX | 11 | Buy | $36.00 | -15.87% | Maintains | 7 months ago |
Sionna Therapeutics IncSION | 2 | Sell | $24.00 | +284.00% | Downgrades | 8 months ago |
Corbus Pharmaceuticals Holdings IncCRBP | 9 | Buy | $53.00 | +443.03% | Maintains | 9 months ago |
Atyr Pharma IncATYR | 2 | Hold | $1.00 | +85.19% | Maintains | 9 months ago |
Pliant Therapeutics IncPLRX | 14 | Hold | $2.00 | +86.92% | Maintains | 9 months ago |
Cidara Therapeutics IncCDTX | 2 | Buy | $145.00 | -34.50% | Maintains | 9 months ago |
Karyopharm Therapeutics IncKPTI | 12 | Buy | $19.00 | +835.96% | Maintains | 9 months ago |
89bio IncETNB | 14 | Hold | $11.00 | N/A | Maintains | a year ago |
Sarepta Therapeutics IncSRPT | 31 | Hold | $23.00 | N/A | Maintains | a year ago |
Applied Therapeutics IncAPLT | 6 | Hold | $1.50 | N/A | Reiterates | a year ago |
Legend Biotech CorpLEGN | 1 | Buy | $84.00 | N/A | Reiterates | a year ago |
Axsome Therapeutics IncAXSM | 2 | Buy | $143.00 | N/A | Maintains | 2 years ago |
Newamsterdam Pharma Co NvNAMS | 1 | Buy | $40.00 | N/A | Reiterates | 2 years ago |
Intra Cellular Therapies IncITCI | 18 | Hold | $132.00 | N/A | Downgrades | 2 years ago |
Igm Biosciences IncIGMS | 15 | Hold | $1.50 | N/A | Downgrades | 2 years ago |
Hookipa Pharma IncHOOK | 11 | Hold | $2.00 | N/A | Downgrades | 2 years ago |
Sage Therapeutics IncSAGE | 19 | Hold | $4.00 | N/A | Upgrades | 2 years ago |
Marinus Pharmaceuticals IncMRNS | 8 | Hold | $1.00 | N/A | Maintains | 2 years ago |
Ambrx Biopharma IncAMAM | 3 | Buy | $32.00 | N/A | Maintains | 3 years ago |
Karuna Therapeutics IncKRTX | 7 | Buy | $225.00 | N/A | Maintains | 3 years ago |
Enanta Pharmaceuticals IncENTA | 14 | Hold | $15.00 | N/A | Maintains | 3 years ago |
Intercept Pharmaceuticals IncICPT | 11 | Hold | $19.00 | N/A | Maintains | 3 years ago |
Ataibeckley IncATAI | 3 | Hold | $9.00 | N/A | Maintains | 4 years ago |
Merus NvMRUS | 3 | Hold | $33.00 | N/A | Maintains | 5 years ago |
Constellation Pharmaceuticals IncCNST | 1 | Hold | $34.00 | N/A | Downgrades | 5 years ago |
Metacrine IncMTCR | 1 | Buy | $25.00 | N/A | Initiates Coverage On | 6 years ago |
Neubase Therapeutics IncNBSE | 1 | Buy | $320.00 | N/A | Initiates Coverage On | 6 years ago |
Celgene CorpCELG | 2 | Buy | $118.00 | N/A | Downgrades | 8 years ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Strong Buy | N/A | N/A | Upgrades | 9 years ago |
Epizyme IncEPZM | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Alder Biopharmaceuticals IncALDR | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 9 years ago |
Immune Design CorpIMDZ | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 9 years ago |
Avexis IncAVXS | 1 | Hold | $92.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.